Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

InstaRX vs RestorLife Med

InstaRX
Graded #253

Higher grade

vs+0.5999999999999943
RestorLife Med
Graded #261

Lower grade

The verdict

InstaRX takes it — 63.8/100 to 63.2/100, but only just.

InstaRX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. InstaRX is a multi-product compounded-medication telehealth platform offering GLP-1 injections (semaglutide and tirzepatide) alongside anti-aging peptides (NAD+, Sermorelin, B12/MIC) and sexual-health… RestorLife Med is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueInstaRX +34
60
26
Dose & formulationEven
64
64
Clinical oversightRestorLife Med +25
72
97
Labs & monitoringRestorLife Med +14
52
66
FulfillmentRestorLife Med +19
78
97
Contract termsInstaRX +18
55
37
InstaRX · left barRestorLife Med · right bar

The numbers

MetricInstaRXRestorLife Med
WeighScore63.8/10063.2/100
GradeCC
Scorecard rank#253#261
Semaglutide$199/mo (starting dose, compounded)$299/mo (microdose tier, compounded)
Tirzepatide$199/mo (starting dose, compounded)$399/mo (microdose tier, compounded)
CoverageAll 50 statesAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
InstaRX

Graded #253 · C

Strengths

  • Available in all 50 states plus DC
  • Manage GLP-1, anti-aging peptides, and sexual-health medications on one account
  • Offers both compounded semaglutide and compounded tirzepatide
  • Independent provider group (Dr Telx) named in the Terms of Service

Where it loses points

  • No per-dose or monthly pricing published — only a "$199 to get started" hook; you can't compare costs before intake
  • No LegitScript, HIPAA, or NABP accreditation shown on public pages
  • Compounding pharmacy not named — only "U.S. pharmacies"
  • Terms of Service reads like generic boilerplate, including copy-paste language about women's health issues — suggests low template hygiene
  • Delaware governing law for disputes despite a California corporate address
RestorLife Med

Graded #261 · C

Strengths

  • Verifiable LegitScript certification (seal ID 50400451) plus a named board-certified physician (Dr. Michael Wasef, MD) licensed in all 50 states
  • Full GLP-1 lineup: compounded semaglutide and tirzepatide, plus gentler microdose entry options
  • Generous support — unlimited care-team messaging, monthly check-ins, dosage adjustments, and 1 free blood test per quarter on the GLP-1 protocols
  • Available in all 50 states with free priority shipping, discreet packaging, and roughly 48-hour delivery
  • Transparent multi-month pricing with 50% off your first month; semaglutide protocols are compounded with B12

Where it loses points

  • Compounded medications are not FDA-approved as finished products (the site discloses this) — not brand Wegovy, Ozempic, Zepbound, or Mounjaro
  • Ongoing pricing is mid-range ($299/mo semaglutide, $399/mo tirzepatide) after the discounted first month
  • The specific partner compounding pharmacy is not named
  • Also markets hormone therapy and anti-aging peptides, not GLP-1 exclusively

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard